Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 19.72
+0.32 (1.65%)
Sep 30, 2026, 3:00 PM CST
SHA:600332 Market Cap
SHA:600332 has a market cap or net worth of 30.23 billion as of October 1, 2026. Its market cap has decreased by -23.45% in one year.
Market Cap
30.23B
Enterprise Value
26.76B
Revenue
77.91B
Ranking
n/a
PE Ratio
12.51
Stock Price
19.72
ChartMarket Cap Chart
Since February 6, 2001, SHA:600332's market cap has increased from 3.73B to 30.23B, an increase of 710.81%. That is a compound annual growth rate of 8.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 30.23B | -23.84% |
| Dec 31, 2025 | 39.69B | -9.21% |
| Dec 31, 2024 | 43.72B | -1.87% |
| Dec 29, 2023 | 44.55B | -3.89% |
| Dec 30, 2022 | 46.36B | -11.03% |
| Dec 31, 2021 | 52.10B | 16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 52.83B |
| Jointown Pharmaceutical Group | 24.58B |
| China National Medicines Corporation | 19.47B |
| Liaoning Cheng Da | 15.34B |
| Qingdao Baheal Medical INC. | 13.16B |
| China Meheco Group | 13.13B |
| China National Accord Medicines Corporation | 11.19B |
| C.Q. Pharmaceutical Holding | 8.91B |